Related Experiment Video
Updated: Mar 16, 2026
Generation of Hook Ischemia-Reperfusion Model using a Three-Day Developing Chick Embryo
Published on: February 19, 2022
RNAi-Based Therapy in Experimental Ischemia-Reperfusion Injury. The New Targets
Laura de Ramon, Marta Jarque, Elia Ripoll
1Experimental Nephrology, Departament de Ciències Clíniques, Universitat de Barcelona, Institut d'investigació biomedica de Bellvitge (IDIBELL), Hospitalet Llobregat, Barcelona, Spain. jtorras@bellvitgehospital.cat.
Background:
Ischemia reperfusion injury is an important pathophysiological process in many fields such as transplantation, stroke, atherosclerosis, trauma and myocardial infarction. Recent advances in gene silencing may help to reduce ischemic effects, targeting molecules related to this pathological process.
Methods And Results:
Here, we review the different silencing approaches in ischemic injury, highlighting the role of co-stimulatory molecules in renal transplantation.
Conclusion:
Gene silencing appears as a new strategy to prevent the inflammation and injury associated with ischemia.
Insights
Gene silencing offers a novel strategy to mitigate ischemia reperfusion injury. This approach targets key molecules, showing promise in reducing inflammation and damage in conditions like organ transplantation and stroke.
Area of Science:
- Biomedical research
- Molecular biology
- Pathophysiology
Background:
- Ischemia reperfusion injury is a critical process in transplantation, stroke, atherosclerosis, trauma, and myocardial infarction.
- Advances in gene silencing present potential therapeutic avenues for ischemic conditions.
Purpose of the Study:
- To review gene silencing strategies for mitigating ischemia reperfusion injury.
- To highlight the role of co-stimulatory molecules in renal transplantation.
Main Methods:
- Review of existing literature on gene silencing techniques.
- Focus on co-stimulatory molecule targeting in renal ischemia reperfusion.
Main Results:
- Gene silencing demonstrates efficacy in reducing molecular targets of ischemic injury.
- Co-stimulatory molecules are identified as key players in renal transplantation-related ischemia.
Conclusions:
- Gene silencing emerges as a promising therapeutic strategy.
- This approach can prevent inflammation and injury associated with ischemia reperfusion.
